Dysregulation of Extracellular Adenosine Levels by Vascular Smooth Muscle Cells From Spontaneously Hypertensive Rats
- 1 February 2001
- journal article
- other
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 21 (2) , 249-254
Abstract
—The objective of this investigation was to determine whether the regulation of extracellular adenosine levels by smooth muscle cells (SMCs) from conduit arteries (aorta) and resistance microvessels (renal arterioles) is different in spontaneously hypertensive rats (SHR) versus normotensive Wistar-Kyoto (WKY) rats. Basal extracellular adenosine levels were decreased in cultured aortic and arteriolar SHR SMCs, and the increase in extracellular adenosine levels induced by stimulation of the cAMP-adenosine pathway was less in aortic and arteriolar SHR SMCs. Extracellular adenosine levels were lower in SHR SMCs, however, even when the cAMP-adenosine pathway was inhibited with 3-isobutyl-1-methylxanthine. Inhibition of adenosine kinase with iodotubercidin and inhibition of adenosine deaminase with erythro-9-(2-hydroxy-3-nonyl) adenine increased extracellular adenosine; however, only inhibition of adenosine deaminase equalized extracellular adenosine levels in SHR versus WKY SMCs. Membrane-disrupted SHR SMCs metabolized exogenous adenosine faster than WKY SMCs did, and this difference was abolished by inhibition of adenosine deaminase but not adenosine kinase. SHR SMCs demonstrated a greater proliferative response than WKY SMCs. This enhanced proliferative response was not blocked by adenosine per se or inhibition of adenosine kinase but was blocked by inhibition of adenosine deaminase and by 2-chloroadenosine (adenosine deaminase–resistant adenosine analogue). We conclude that dysregulation of extracellular adenosine levels exists in SHR SMCs, that this dysregulation is not due to a defect in the cAMP-adenosine pathway but rather to enhanced activity of adenosine deaminase, and that the dysregulation of extracellular adenosine mediates the enhanced proliferative response of SHR SMCs.Keywords
This publication has 25 references indexed in Scilit:
- Factors controlling growth and matrix production and matrix production in vascular smooth muscle and glomerular mesangial cellCurrent Opinion in Nephrology and Hypertension, 1997
- Smooth Muscle Cell–Derived Adenosine Inhibits Cell GrowthHypertension, 1996
- Harnessing an endogenous cardioprotective mechanism: Cellular sources and sites of action of adenosineJournal of Molecular and Cellular Cardiology, 1995
- A2‐purinoceptor‐mediated relaxation in the guinea‐pig coronary vasculature: a role for nitric oxideBritish Journal of Pharmacology, 1993
- Adenosine: A Physiological Brake on Renin ReleaseAnnual Review of Pharmacology and Toxicology, 1991
- Influence of blood pressure on development of aortic medial smooth muscle hypertrophy in spontaneously hypertensive rats.Hypertension, 1987
- Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells.Journal of Clinical Investigation, 1986
- Contribution of coronary endothelial cells to cardiac adenosine productionPflügers Archiv - European Journal of Physiology, 1986
- Renal afferent arteriole in the spontaneously hypertensive rat.Hypertension, 1983
- Modulation of the evoked release of noradrenaline in canine saphenous vein via presynaptic receptors for adenosine but not ATPEuropean Journal of Pharmacology, 1979